Your browser version may not work well with NCBI's Web applications. More information here...
1: Int J Clin Pract. 2006 Jan;60(1):80-4.Click here to read Links

Thyroid cancer review 3: management of medullary and undifferentiated thyroid cancer.

Nix PA, Nicolaides A, Coatesworth AP.

Department of Otolaryngology, Head and Neck Surgery, York Hospital, York, UK.

This is the last of the three review articles dealing with thyroid cancer. Over 90% of thyroid cancer is of the differentiated type associated with a very good 10-year disease-free survival rate. In contrast, the rare forms of thyroid cancer which comprise medullary thyroid cancer arising from parafollicluar C cells, Hurthle cell carcinoma, anaplastic carcinoma, thyroid lymphoma and squamous cell carcinoma are typically associated with a poorer survival rate. Management is based upon small retrospective cohort studies.

PMID: 16409432 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Thyroid (Armour® Thyroid)

    Thyroid is a hormone produced by the body. When taken correctly, thyroid is used to treat the symptoms of hypothyroidism (a condition where the thyroid gland does not produce enough thyroid hormone). Symptoms of hypothyr...

  • Source: AHFS Consumer Medication Information